pirfenidone has been researched along with Liver Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar, JR; Alonso-Campero, R; Bernal-Reyes, R; Gamino, ME; Gasca, F; Gomez-Silva, M; Hernández, L; Hernández, N; la Parra, MG; Muñoz-Espinosa, LE; Peña, P; Pineyro-Garza, E; Poo, JL; Tapia, G | 1 |
| Aguilar-Ramírez, JR; Armendariz-Borunda, J; Bosques-Padilla, F; Cerda, E; Cisneros, L; Cruz, M; Flores-Murrieta, F; Gasca, F; Hernández, L; Mejía-Cuán, L; Muñoz-Espinosa, LE; Patiño, A; Poo, JL; Ramírez-Castillo, C; Tapia, G; Torre, A; Treviño, S; Velázquez, A | 1 |
| Kaibori, M; Kamiyama, Y; Kwon, AH; Okumura, T; Tsuchiya, H; Yanagida, H; Yokoigawa, N | 1 |
| Chen, XY; Wang, F; Wen, T; Wu, H | 1 |
1 trial(s) available for pirfenidone and Liver Diseases
| Article | Year |
|---|---|
Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study.
Topics: Anti-Inflammatory Agents; Delayed-Action Preparations; Disease Progression; Elasticity Imaging Techniques; Female; Humans; Liver; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Proof of Concept Study; Pyridones; Quality of Life; Standard of Care; Treatment Outcome | 2020 |
3 other study(ies) available for pirfenidone and Liver Diseases
| Article | Year |
|---|---|
Prolonged release pirfenidone pharmacokinetics is modified in cirrhosis GENESIS study.
Topics: Area Under Curve; Humans; Liver Cirrhosis; Liver Diseases; Pyridones | 2023 |
Pirfenidone prevents endotoxin-induced liver injury after partial hepatectomy in rats.
Topics: Animals; Chemokines, CXC; Cytokines; Endotoxemia; Hepatectomy; Inflammation Mediators; Intercellular Signaling Peptides and Proteins; Liver; Liver Diseases; Male; Necrosis; Neutrophil Infiltration; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pyridones; Rats; Rats, Sprague-Dawley; Survival Rate; Transcription Factors | 2004 |
Protective effects of pirfenidone on D-galactosamine and lipopolysaccharide-induced acute hepatotoxicity in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Inflammation; Lipid Peroxidation; Lipopolysaccharides; Liver; Liver Diseases; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Pyridones; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2008 |